THC Biomed Intl Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for THC Biomed Intl.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 53.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Oct 11
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Jun 26Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Mar 13Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Aug 30We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt
Mar 25Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Dec 02Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Jun 01Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long
Apr 06Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?
Jan 08In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as THC Biomed Intl has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2023 | 2 | -4 | 0 | 0 | N/A |
| 1/31/2023 | 2 | -3 | -1 | -1 | N/A |
| 10/31/2022 | 2 | -3 | -2 | -1 | N/A |
| 7/31/2022 | 2 | -3 | -2 | -2 | N/A |
| 4/30/2022 | 2 | -3 | -2 | -2 | N/A |
| 1/31/2022 | 3 | -4 | -2 | -2 | N/A |
| 10/31/2021 | 3 | -6 | -2 | -1 | N/A |
| 7/31/2021 | 3 | -6 | -1 | -1 | N/A |
| 4/30/2021 | 3 | -6 | -1 | -1 | N/A |
| 1/31/2021 | 2 | -5 | -1 | 0 | N/A |
| 10/31/2020 | 3 | -2 | -1 | 0 | N/A |
| 7/31/2020 | 3 | 0 | -1 | 0 | N/A |
| 4/30/2020 | 3 | -4 | -3 | -1 | N/A |
| 1/31/2020 | 3 | -8 | -6 | -1 | N/A |
| 10/31/2019 | 2 | -13 | -8 | -1 | N/A |
| 7/31/2019 | 1 | -13 | -9 | -2 | N/A |
| 4/30/2019 | 1 | -12 | -10 | -2 | N/A |
| 1/31/2019 | 1 | -7 | -11 | -3 | N/A |
| 10/31/2018 | 1 | -12 | -10 | -3 | N/A |
| 7/31/2018 | 1 | -12 | -8 | -2 | N/A |
| 4/30/2018 | 1 | -10 | -6 | -2 | N/A |
| 1/31/2018 | 1 | -11 | -3 | -1 | N/A |
| 10/31/2017 | 0 | -1 | -2 | -1 | N/A |
| 7/31/2017 | 0 | -1 | -3 | -1 | N/A |
| 4/30/2017 | 0 | 0 | -2 | -1 | N/A |
| 1/31/2017 | 0 | 1 | N/A | -1 | N/A |
| 10/31/2016 | N/A | 1 | N/A | -2 | N/A |
| 7/31/2016 | N/A | -1 | N/A | -1 | N/A |
| 4/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 1/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 10/31/2015 | N/A | -3 | N/A | 0 | N/A |
| 7/31/2015 | N/A | -3 | N/A | 0 | N/A |
| 4/30/2015 | N/A | -2 | N/A | -1 | N/A |
| 1/31/2015 | N/A | -2 | N/A | 0 | N/A |
| 10/31/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if THC's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if THC's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if THC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if THC's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if THC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if THC's Return on Equity is forecast to be high in 3 years time